| Reducing GABAA α5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome C Martínez-Cué, P Martínez, N Rueda, R Vidal, S García, V Vidal, ... Journal of Neuroscience 33 (9), 3953-3966, 2013 | 191 | 2013 |
| Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome S García-Cerro, P Martínez, V Vidal, A Corrales, J Flórez, R Vidal, ... PloS one 9 (9), e106572, 2014 | 111 | 2014 |
| Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes S García-Cerro, N Rueda, V Vidal, S Lantigua, C Martínez-Cué Neurobiology of disease 106, 76-88, 2017 | 93 | 2017 |
| Long‐term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle‐aged T s65 D n mice, a model of D own … A Corrales, P Martínez, S García, V Vidal, E García, J Flórez, ... Journal of pineal research 54 (3), 346-358, 2013 | 84 | 2013 |
| Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder N Rodríguez, A Morer, EA González-Navarro, C Serra-Pages, D Boloc, ... Journal of neuroinflammation 14, 1-11, 2017 | 65 | 2017 |
| Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of D own syndrome A Corrales, R Vidal, S García, V Vidal, P Martínez, E García, J Flórez, ... Journal of pineal research 56 (1), 51-61, 2014 | 59 | 2014 |
| Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer’s disease M Izco, P Martinez, A Corrales, N Fandos, S Garcia, D Insua, M Montanes, ... Neuroscience 263, 269-279, 2014 | 47 | 2014 |
| Chronic melatonin administration reduced oxidative damage and cellular senescence in the hippocampus of a mouse model of down syndrome EB Parisotto, V Vidal, S García-Cerro, S Lantigua, D Wilhelm Filho, ... Neurochemical research 41, 2904-2913, 2016 | 38 | 2016 |
| Lack of behavioral and cognitive effects of chronic ethosuximide and gabapentin treatment in the Ts65Dn mouse model of Down syndrome V Vidal, S García, P Martínez, A Corrales, J Flórez, N Rueda, A Sharma, ... Neuroscience 220, 158-168, 2012 | 27 | 2012 |
| Anti-IL17 treatment ameliorates Down syndrome phenotypes in mice N Rueda, V Vidal, S García-Cerro, JO Narcís, M Llorens-Martín, ... Brain, Behavior, and Immunity 73, 235-251, 2018 | 24 | 2018 |
| Prenatal administration of oleic acid or linolenic acid reduces neuromorphological and cognitive alterations in Ts65dn down syndrome mice S García-Cerro, N Rueda, V Vidal, A Puente, V Campa, S Lantigua, ... The Journal of nutrition 150 (6), 1631-1643, 2020 | 21 | 2020 |
| Decreasing the Expression of GABAA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal … V Vidal, S García-Cerro, P Martínez, A Corrales, S Lantigua, R Vidal, ... Molecular neurobiology 55, 4745-4762, 2018 | 18 | 2018 |
| Pre-and post-natal melatonin administration partially regulates brain oxidative stress but does not improve cognitive or histological alterations in the Ts65Dn mouse model of … A Corrales, EB Parisotto, V Vidal, S García-Cerro, S Lantigua, M Diego, ... Behavioural Brain Research 334, 142-154, 2017 | 18 | 2017 |
| Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics D Boloc, A Gortat, JQ Cheng-Zhang, S García-Cerro, N Rodríguez, ... Translational Psychiatry 8 (1), 276, 2018 | 17 | 2018 |
| Cerebellar alterations in a model of Down syndrome: The role of the Dyrk1A gene S García-Cerro, V Vidal, S Lantigua, MT Berciano, M Lafarga, ... Neurobiology of Disease 110, 206-217, 2018 | 17 | 2018 |
| Microarray gene-expression study in fibroblast and lymphoblastoid cell lines from antipsychotic-naïve first-episode schizophrenia patients P Gassó, S Mas, N Rodríguez, D Boloc, S García-Cerro, M Bernardo, ... Journal of Psychiatric Research 95, 91-101, 2017 | 14 | 2017 |
| Bexarotene impairs cognition and produces hypothyroidism in a mouse model of down syndrome and Alzheimer’s disease V Vidal, A Puente, S García-Cerro, MT García Unzueta, N Rueda, ... Frontiers in Pharmacology 12, 613211, 2021 | 12 | 2021 |
| Reducing GABAA a5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome C Martınez-Cué, P Martınez, N Rueda, R Vidal, S Garcıa, V Vidal, ... J Neurosci 33, 3953-3966, 2013 | 12 | 2013 |
| miRNAs as biomarkers of autism spectrum disorder: a systematic review and meta-analysis N Garrido-Torres, K Guzmán-Torres, S García-Cerro, G Pinilla Bermúdez, ... European Child & Adolescent Psychiatry, 1-34, 2023 | 11 | 2023 |
| The positive allosteric modulator of the mGlu2 receptor JNJ-46356479 partially improves neuropathological deficits and schizophrenia-like behaviors in a postnatal ketamine mice … A Martínez-Pinteño, S García-Cerro, S Mas, T Torres, D Boloc, ... Journal of Psychiatric Research 126, 8-18, 2020 | 11 | 2020 |
Andrea Corrales PardoIDIVAL-HUMV/Universidad Europea del Atlántico在 uneatlantico.es 的电子邮件经过验证
